Welcome to the e-CCO Library!

P714: Efficacy and safety of infliximab retreatment in luminal Crohn’s disease: a multi-centre, prospective, observational cohort (REGAIN) study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Boschetti*1, B. Pariente2, D. Laharie3, X. Roblin4, C. Gilletta5, A. Aubourg6, A. Bourreille7, C. Zallot8, X. Hebuterne9, A. Buisson10, J-C. Grimaud11, Y. Bouhnik12, M. Allez13, R. Altwegg14, S. Viennot15, L. Vuitton16, F. Carbonnel17, M. Nachury2, S. Paul18, J. Lambert19, L. Peyrin-Biroulet8, Getaid1

Created: Friday, 22 February 2019, 9:41 AM
P714: Mucosal healing in CD with vedolizumab versus other biologics: endoscopic outcomes during long-term routine care in a multinational observational study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Siegel, C.(1)*;Sebastian, S.(2);Siegmund, B.(3);Zhou, J.(4);Jones, S.(5);Adsul, S.(4);Louis, E.(6);
Created: Friday, 14 July 2023, 11:12 AM
P714: Vedolizumab, an adequate option in medically refractory and thiopurine-intolerant inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Iborra1*, N. Maroto2, P. Navarro-Cortes3, B. Beltran1, M. Boscá-Watts3, I. Ferrer2, N. Garcia-Morales1, E. Sáez-González1, J. Hinojosa2, M. Minguez3, P. Nos1

Created: Thursday, 21 February 2019, 9:14 AM
P714: Vitamin D deficiency in inflammatory bowel disease: prevalence and relation to disease activity in a cohort of patients of a Mediterranean country
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Branco J.C., Cardoso M., Anapaz V., Lourenço L., Oliveira A.M., Rodrigues C.G., Santos L., Reis J.

Created: Wednesday, 20 February 2019, 10:36 AM
P715 The prevalence of chronic musculoskeletal pain in patients with ulcerative colitis in comparison to control subjects: A cross-sectional study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Pettersson1, F. Kragsbjerg1, A. Hamrin2, H. Forsblad-D′elia3, P. Karling1

Created: Thursday, 30 January 2020, 10:12 AM
P715: Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vermeire, S.(1)*;Colombel, J.F.(2);Rubin, D.T.(3);Ghosh, S.(4);Jain, A.(5);Lawlor, G.(5);Osterman, M.T.(5);Wu, H.(5);Canavan, J.B.(5);Chiorean, M.V.(6);
Created: Friday, 14 July 2023, 11:12 AM
P715: Opioid use in patients with inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

X. Lin, J. Lofland, L. Zhang, K. Lee, S. Sloan*, L. Chamaa, C. Marano, S. Plevy

Created: Thursday, 21 February 2019, 9:14 AM
P715: Real-world tofacitinib effectiveness and safety in patients with refractory ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Lair-Mehiri*1, C. Stefanescu1, T. Vaysse2, D. Laharie3, X. Roblin4, I. Rosa5, X. Treton1, V. Abitbol6, A. Amiot7, G. Bouguen8, N. Dib9, M. Fumery10, B. Pariente11, F. Carbonnel2, L. Peryn-Biroulet12, M. Simon13, S. Viennot14, Y. Bouhnik1

Created: Friday, 22 February 2019, 9:41 AM
P715: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease: results from a single-center in 2004, 2009 and 2014
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Huh G.*1, Yoon H.2, Choi Y.J.2, Park Y.S.2, Kim N.1,2, Lee D.H.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P716 Clinical significance of residual non-rectal inflammation in ulcerative colitis patients with clinical remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Shin, G. Seong, J.H. Song, S.M. Kong, T.J. Kim, E.R. Kim, S.N. Hong, D.K. Chang, Y.H. Kim

Created: Thursday, 30 January 2020, 10:12 AM
P716: A 2-week course of Exclusive Enteral Nutrition followed by the Crohn Disease Exclusion Diet is effective for Induction and Maintenance of Remission in children with Crohn Disease; the DIETOMICS-CD trial
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Sigall-Boneh, R.(1,2)*;Manuel Navas-López, V.(3); Hussey, S.(4);Pujol Muncunill, G.(5);Lawrence, S.(6);Jonsson Rolandsdotter, H.(7,8);Otley, A.(9);Martín-de-Carpi5, J.(5);Abramas, L.(1);Herrador López , M.(10);Egea Castillo, N.(11);Chen, M.(12);Hurley, M.(13);Wingate, K.(14);Olen, O.(15,16);yaakov, M.(1);Levine, A.(1,17);Van Limbergen, J.(18,19);Wine, E.(12);
Created: Friday, 14 July 2023, 11:12 AM
P716: Beta-blocker use is associated with a higher relapse risk of inflammatory bowel disease – a Dutch retrospective cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Willemze R.*1, Bakker T.1, Pippias M.2, Ponsioen C.3, de Jonge W.1

Created: Wednesday, 20 February 2019, 10:36 AM
P716: Current smoking trends in British IBD patients in the age of e-cigarettes
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Loonat, R. Sagar, C. Selinger*

Created: Thursday, 21 February 2019, 9:14 AM
P716: Exclusive Enteral Nutrition refurbishes beneficial gut microbiota in patients with Acute Severe Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Bajaj, A.(1);Markandey, M.(1);Sahu, P.(1);Vuyyuru, S.K.(1);Kante, B.(1);Kumar, P.(1);Singh, N.(1);Gupta, A.(1);Singh, M.(1);Verma, M.(1);Makharia, G.(1);Kedia, S.(1);Ahuja, V.(1);
Created: Friday, 11 February 2022, 3:56 PM
P716: The use of tacrolimus in patients with ulcerative colitis resistant to standard medical therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Shafi*1, A. Bedir2, L. Medcalf1, G. Chung-Faye1, B. Hope1, P. Dubois1, B. Hayee1, B. Vadamalayan1, A. J. Kent1

Created: Friday, 22 February 2019, 9:41 AM
P717 Ustekinumab in Crohn’s disease: Real-world outcomes from the Sicilian Network for inflammatory bowel diseases (SN-IBD):–Preliminary results
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Viola1, G. Fiocco1, A. Alibrandi2, F.S. Macaluso3, M. Cappello4, A.C. Privitera5, G. Magrì6, S. Garufi7, A. Centritto1, M. Ventimiglia3, E. Giuffrida4, C. Ferracane6, G. Costantino1, S. Renna3, A. Orlando3, W. Fries1

Created: Thursday, 30 January 2020, 10:12 AM
P717: Comparison of two different techniques to assess vedolizumab trough levels in adult patients with IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Berger1*, C. Christ1, F.-P. Armbruster1, H. Schulze2, A. Dignass2,3, J. Stein3,4, K. Farrag3,4

Created: Thursday, 21 February 2019, 9:14 AM
P717: Faecal Microbiota Transplant in Ulcerative Colitis (FMTUC) – A randomised clinical trial feasibility study
Year: 2022
Source: ECCO'22
Authors: Jitsumura, M.(1,2);Cunningham , A.(1);Hitchings, M.D.(3);Wilkinson, T.(3);Kinross, J.(4);Row, P.(5);Davies, A.(6);Dean Anthony, H.(1);
Created: Friday, 11 February 2022, 3:56 PM
P717: Higher ulcerative colitis/Crohn's disease ratio in a central region of Argentina
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Balderramo D.*1, Herrera-Najum P.2, Trakal J.3, Gonzalez R.1, Zárate F.4, Raiden K.5, Ferrer L.2, Balzola S.5, Defagό M.R.6 Grupo CEMEI (Cooperaciόn para el Estydio y Manejo de la Enfermedad Inflamatoria Intestinal) Cόrdoba, Argentina

Created: Wednesday, 20 February 2019, 10:36 AM